Lucid Medical Diagnostics

Lucid Medical Diagnostics company information, Employees & Contact Information

A comprehensive healthcare facility established in 2007 for the purpose of providing quality laboratory and radiology diagnostic services. Lucid partnered with established leaders in the industry of medical equipment manufacture like General Electric (GE) Medical Systems, Abbott. Team of hands on experience healthcare professionals , 24 Radiologists, 12 Pathologists and Bio Chemists.

Company Details

Employees
197
Founded
-
Address
Plot # 5&6, Sai Nagar Colony,, Kphb Colony,india
Industry
Hospitals And Health Care
NAICS
Health Care and Social Assistance
Social Assistance
HQ
Hyderabad, Telangana
Looking for a particular Lucid Medical Diagnostics employee's phone or email?

Lucid Medical Diagnostics Questions

News

Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors - PR Newswire

Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors PR Newswire

Lucid Diagnostics: Holding Onto Medicare Coverage Hopes (NASDAQ:LUCD) - Seeking Alpha

Lucid Diagnostics: Holding Onto Medicare Coverage Hopes (NASDAQ:LUCD) Seeking Alpha

Lucid Diagnostics earnings beat, revenue was in line with estimates - Investing.com

Lucid Diagnostics earnings beat, revenue was in line with estimates Investing.com

$26.9M Capital Raise: Cancer Diagnostics Firm Lucid Completes Major Public Offering at $1.00 Per Share - Stock Titan

$26.9M Capital Raise: Cancer Diagnostics Firm Lucid Completes Major Public Offering at $1.00 Per Share Stock Titan

Midtown medical testing company raises $27M with the prospect of Medicare coverage - Crain's New York Business

Midtown medical testing company raises $27M with the prospect of Medicare coverage Crain's New York Business

Lucid Diagnostics Announces Proposed Public Offering of Common Stock - PR Newswire

Lucid Diagnostics Announces Proposed Public Offering of Common Stock PR Newswire

Lucid Diagnostics: DNA Testing To Get Medicare Coverage, Driving Volumes, Says Bullish Analyst - Benzinga

Lucid Diagnostics: DNA Testing To Get Medicare Coverage, Driving Volumes, Says Bullish Analyst Benzinga

Lucid Diagnostics’ SWOT analysis: stock faces reimbursement hurdles amid market potential - Investing.com

Lucid Diagnostics’ SWOT analysis: stock faces reimbursement hurdles amid market potential Investing.com

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results - PR Newswire

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results PR Newswire

Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025 - Yahoo Finance

Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025 Yahoo Finance

Lucid Diagnostics to Participate in Upcoming Investor Conferences - PR Newswire

Lucid Diagnostics to Participate in Upcoming Investor Conferences PR Newswire

Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025 - Yahoo Finance

Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025 Yahoo Finance

Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results - PR Newswire

Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results PR Newswire

Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test - PR Newswire

Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test PR Newswire

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering - PR Newswire

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering PR Newswire

Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology - PR Newswire

Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology PR Newswire

Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs - PR Newswire

Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs PR Newswire

Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes - Yahoo Finance

Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes Yahoo Finance

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication - PR Newswire

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication PR Newswire

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones - PR Newswire

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones PR Newswire

Lucid Diagnostics Joins Elite Russell Indexes, Opens Door to $10.6T Investment Pool - Stock Titan

Lucid Diagnostics Joins Elite Russell Indexes, Opens Door to $10.6T Investment Pool Stock Titan

Lucid Diagnostics Stock Sinks After-Hours On Equity Raise, But Retail Dives In Anyway - Stocktwits

Lucid Diagnostics Stock Sinks After-Hours On Equity Raise, But Retail Dives In Anyway Stocktwits

Lucid Diagnostics faces Nasdaq delisting over share price - Investing.com

Lucid Diagnostics faces Nasdaq delisting over share price Investing.com

Lucid Diagnostics completes $70 million initial public offering - Case Western Reserve University

Lucid Diagnostics completes $70 million initial public offering Case Western Reserve University

Lucid Diagnostics prepares to leave the PAVmed nest with $57M IPO filing - Fierce Biotech

Lucid Diagnostics prepares to leave the PAVmed nest with $57M IPO filing Fierce Biotech

Lucid Diagnostics (LUCD) - Zacks Investment Research

Lucid Diagnostics (LUCD) Zacks Investment Research

Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Rating of “Moderate Buy” from Brokerages Defense World

Lucid Diagnostics (NASDAQ:LUCD) Downgraded to “Sell” Rating by Wall Street Zen - Defense World

Lucid Diagnostics (NASDAQ:LUCD) Downgraded to “Sell” Rating by Wall Street Zen Defense World

Top Lucid Medical Diagnostics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant